Equator Therapeutics

Equator Therapeutics

Biotechnology Research San Francisco, California, United States 6 employees
Employees
6
Contacts
3
Emails
3
Phones
2

Equator Therapeutics Overview

Headquarters
San Francisco, California, United States
Industry
Biotechnology Research
Employees
6
Funding
500.0K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Equator Therapeutics

Our drug will target mitochondria – the powerhouse of the cell – to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.

Equator Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Equator Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Simon Vu Principal Scientist
Email
Yuriy Kirichok Professor at Washington University School of Medicine
Email Phone
David Segura CEO @ Glassbox Media - Digital Media, Podcasting, Tv & Film
Email Phone
Sebastian A. Brunemeier Longbio - Drug Hunter-gatherer - Gp @ Healthspan Capital
View

Employees by Management Level

Executive 2 profiles
Individual contributor 2 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0
Executive 1 1 0

Compare Similar Companies to Equator Therapeutics